Key HIV Care Teams Let Go, Putting Mothers and Children at Risk

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 9, 2025.

By I. Edwards HealthDay Reporter

WEDNESDAY, April 9, 2025 -- The Trump administration has let go of the last remaining U.S. health officials who oversaw HIV care for more than 1.1 million mothers and children in low-income countries.

The move raises alarms about how these vulnerable groups will get care.

The officials — who worked in multiple U.S. agencies, including the Centers for Disease Control and Prevention (CDC), State Department and the U.S. Agency for International Development (USAID) — managed programs funded through the President’s Emergency Plan For AIDS Relief (PEPFAR).

These efforts help prevent HIV transmission from mothers to babies and treat children who are already infected. But those teams were eliminated last week during an abrupt reorganization.

“We hope this is not a sign that treating mothers and children is no longer important in PEPFAR, and that this is a mistake that can be corrected,” a federal health official who asked not to be named, told The New York Times.

Though PEPFAR funding still exists, there’s now a shortage of staff to run the programs, The Times said.

It’s unclear how the money will be used without the experts who oversaw 300 grants across more than 40 countries.

"We were totally blindsided that the whole unit at CDC is being terminated," said Dr. Anja Giphart, executive vice president of medical and scientific affairs at the Elizabeth Glaser Pediatric AIDS Foundation.

Her group relies on the CDC for 60% of its funding and only has money promised through September.

According to a study published Tuesday in The Lancet, cutting off PEPFAR support could lead to 1 million new HIV infections and nearly 500,000 AIDS-related deaths in children by 2030.

In places like sub-Saharan Africa, one child under age 15 dies from AIDS every seven minutes, The Times reported.

What's more, pregnant women with HIV often get treatment at prenatal clinics, which lowers the risk of infecting their babies from 1 in 3 to less than 1%, according to National Institutes of Health data.

CDC staff had been helping countries plan for new HIV drug deliveries and tracking medicine shortages caused by the January foreign aid freeze. Now, that coordination has disappeared.

“This coordination is especially critical right now because we’re in a period of immense change,” the anonymous CDC official said.

"Time is of the essence,” Giphart agreed. “That seems to not really be taken into consideration with all these changes that are being made.”

Sources

  • The New York Times, April 8, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-10 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords